View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
Healthcare Team
  • Healthcare Team
PREMIUM
EVT EVOTEC SE
DBV DBV Technologie... ... (+11)

Transfer of coverage

From 1st July, Bruno Bulic will be in charge of the following stocks:BasileaAbivaxAchillesDBVEvotecGeneuroGenfitInnate pharmaInventivaValerioValneva

EVT EVOTEC SE
DBV DBV TECHNOLOGIES SA
BSLN BASILEA PHARMACEUTICA AG
IPH INNATE PHARMA SA CLASS A
VLS VALNEVA SE
GNFT GENFIT SA
GNRO GENEURO SA
IVA INVENTIVA ADS
ACHL ACHILLES THERAPEUTICS PLC
ABVX ABIVAX
ALONX VALERIO THEARPEUTICS
07/01/24 July 1, 2024 1 EN
Healthcare Team
  • Healthcare Team
ACHL ACHILLES THERAPEUTICS PLC
05/11/23 May 11, 2023 1 EN
Ingird Gafanhão
  • Ingird Gafanhão
PREMIUM
ACHL ACHILLES THERAP...

Reports Q1 results, discloses neoantigen immunogenicity prediction app...

Achilles reported Q1 2023 results with operating expenses of USD 18.6m (USD 19m) and a cash position of USD 158.5m (FY 2022: USD 173.3m) that provides a runway into mid-2025. The company reiterated that clinical and translational data in NSCLC and melanoma should be disclosed in Q4 2023, and that t

ACHL ACHILLES THERAPEUTICS PLC
05/11/23 May 11, 2023 1 EN
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch